We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24B
AUM Growth
+$1.05B
Cap. Flow
-$221M
Cap. Flow %
-0.92%
Top 10 Hldgs %
13.73%
Holding
1,494
New
103
Increased
612
Reduced
406
Closed
115

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$114M
2
AET
Aetna Inc
AET
+$96.3M
3
TRV icon
Travelers Companies
TRV
+$94.5M
4
CHK
Chesapeake Energy Corporation
CHK
+$89M
5
AEE icon
Ameren
AEE
+$69.4M

Top Sells

Rank Stock Value
1
DB icon
Deutsche Bank
DB
+$247M
2
VZ icon
Verizon
VZ
+$186M
3
MDT icon
Medtronic
MDT
+$150M
4
LO
LORILLARD INC COM STK
LO
+$126M
5
JCI icon
Johnson Controls International
JCI
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 15.44%
2 Technology 14.68%
3 Financials 12.75%
4 Industrials 11.1%
5 Energy 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IEO icon
451
iShares US Oil & Gas Exploration & Production ETF
IEO
$746M
$7.23M 0.03%
74,470
+120
+0.2% +$11K
POWI icon
452
Power Integrations
POWI
$2.7B
$7.22M 0.03%
251,000
-91,000
-27% -$2.54M
AMAT icon
453
Applied Materials
AMAT
$334B
$7.18M 0.03%
318,259
+1,700
+0.5% +$34.7K
HY icon
454
Hyster-Yale Materials Handling
HY
$599M
$7.15M 0.03%
80,781
+3,180
+4% +$289K
EQT icon
455
EQT Corp
EQT
$33.2B
$7.13M 0.03%
122,616
-16,831
-12% -$965K
HOLX
456
DELISTED
Hologic
HOLX
$7.13M 0.03%
281,308
-57,925
-17% -$1.35M
MYGN icon
457
Myriad Genetics
MYGN
$371M
$7.11M 0.03%
182,734
-11,328
-6% -$421K
BCR
458
DELISTED
CR Bard Inc.
BCR
$7.11M 0.03%
49,732
+32,794
+194% +$4.69M
BYI
459
DELISTED
BALLY TECHNOLOGIES, INC.
BYI
$7.09M 0.03%
107,940
-136,900
-56% -$8.55M
VTR icon
460
Ventas
VTR
$45.4B
$7.07M 0.03%
96,542
-46,817
-33% -$3.48M
MMP
461
DELISTED
Magellan Midstream Partners, L.P.
MMP
$7.06M 0.03%
84,000
-5,000
-6% -$392K
XYL icon
462
Xylem
XYL
$25.1B
$7.04M 0.03%
180,200
-7,000
-4% -$262K
XEC
463
DELISTED
CIMAREX ENERGY CO
XEC
$6.99M 0.03%
48,709
+10,353
+27% +$1.32M
AVGO icon
464
Broadcom
AVGO
$1.62T
$6.97M 0.03%
966,710
+72,690
+8% +$488K
SKX
465
DELISTED
Skechers
SKX
$6.95M 0.03%
+456,000
New +$6.29M
DXCM icon
466
DexCom
DXCM
$32.6B
$6.93M 0.03%
698,720
-12,964
-2% -$115K
EW icon
467
Edwards Lifesciences
EW
$49.4B
$6.88M 0.03%
481,230
-8,466
-2% -$115K
TWC
468
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$6.87M 0.03%
46,632
-20,270
-30% -$2.84M
COF icon
469
Capital One
COF
$127B
$6.86M 0.03%
83,047
+5,941
+8% +$462K
LUMO
470
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$6.85M 0.03%
28,669
-818
-3% -$166K
LMT icon
471
Lockheed Martin
LMT
$123B
$6.85M 0.03%
42,610
+12,100
+40% +$1.97M
PODD icon
472
Insulet
PODD
$9.66B
$6.84M 0.03%
172,359
+30,474
+21% +$1.17M
TRMB icon
473
Trimble
TRMB
$13.7B
$6.84M 0.03%
185,000
-88,000
-32% -$3.29M
CVE icon
474
Cenovus Energy
CVE
$62.6B
$6.79M 0.03%
209,089
-61,441
-23% -$1.83M
CAM
475
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
$6.68M 0.03%
98,600
+6,200
+7% +$399K
17 18
19
20 21

Similar funds

VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
FA
Forefront Analytics West Conshohocken, Pennsylvania $92M AUM 25.18% 1-Year Est. Return
PBCM
Point Break Capital Management Miami, Florida $91.7M AUM
CCAM
Crystal Cove Asset Management Newport Beach, California $91.7M AUM
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
AWP
Atlas Wealth Partners Wyomissing, Pennsylvania $91.6M AUM 9.52% 1-Year Est. Return
HI
Hyundai Investments Yeongdeungopo-Gu, Seoul, South Korea $92.3M AUM 0.12% 1-Year Est. Return
DCA
DB&C Advisors Holland, Michigan $92.4M AUM

Axa's Q2 2014 Portfolio in Review

As of Q2 2014, Axa held 1,494 positions worth $24B, up 4.6% from $23B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q2 2014 filing shows 103 new, 612 increased, 406 reduced and 115 closed positions. Its largest new stake was Boston Scientific: 4,394,250 shares worth $56.1M. The largest sale was Deutsche Bank, an estimated $247M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q2 2014 buy was Boston Scientific: 4,394,250 shares worth $56.1M.
  • Axa added most to Gilead Sciences in Q2 2014, an estimated $114M increase.
  • Axa's biggest Q2 2014 reduction was Deutsche Bank, cutting an estimated $247M.
  • Axa fully exited OMNICARE INC in Q2 2014, selling an estimated $20.4M.
  • Axa's ten largest holdings make up 14% of its $24B portfolio in Q2 2014.
  • Axa opened 103 new positions and closed 115 in Q2 2014.
  • Axa's portfolio value rose 4.6% quarter-over-quarter to $24B.

Based on Axa's 13F filing for Q2 2014, filed 13 Aug 2014.